Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Other financing activities (2024 - 2025)

Profound Medical (PROF) has 2 years of Other financing activities data on record, last reported at $1.0 million in Q3 2025.

  • For Q3 2025, Other financing activities changed N/A year-over-year to $1.0 million; the TTM value through Sep 2025 reached $4.2 million, changed N/A, while the annual FY2025 figure was $1.0 million, 79.24% down from the prior year.
  • Other financing activities reached $1.0 million in Q3 2025 per PROF's latest filing, up from $89000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $3.0 million in Q4 2024 and bottomed at $89000.0 in Q1 2025.